GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » bioXXmed AG (XTER:T5O0) » Definitions » EBITDA Margin %

bioXXmed AG (XTER:T5O0) EBITDA Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is bioXXmed AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. bioXXmed AG's EBITDA for the six months ended in Jun. 2024 was €-0.36 Mil. bioXXmed AG's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, bioXXmed AG's EBITDA margin for the quarter that ended in Jun. 2024 was 0.00%.


bioXXmed AG EBITDA Margin % Historical Data

The historical data trend for bioXXmed AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

bioXXmed AG EBITDA Margin % Chart

bioXXmed AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,208.33 -5,047.22 -3,262.22 -6,525.00 -4,629.41

bioXXmed AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,825.00 -4,150.00 -2,558.33 -9,580.00 -

Competitive Comparison of bioXXmed AG's EBITDA Margin %

For the Biotechnology subindustry, bioXXmed AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


bioXXmed AG's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, bioXXmed AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where bioXXmed AG's EBITDA Margin % falls into.



bioXXmed AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

bioXXmed AG's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.787/0.017
=-4,629.41 %

bioXXmed AG's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.358/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


bioXXmed AG  (XTER:T5O0) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


bioXXmed AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of bioXXmed AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


bioXXmed AG Business Description

Traded in Other Exchanges
Address
Riedstrasse 2, Darmstadt, HE, DEU, 64295
bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.

bioXXmed AG Headlines

No Headlines